Calif. Medical Experts Find That Gilead’s New Hepatitis C Pill has ‘Low Value’ Compared With Other Drugs
On Monday, a group of California medical experts voted that a new hepatitis C drug made by Gilead Sciences that costs $1,000 per pill is of "low value" compared with older, less expensive medications to treat the virus. The decision was included in a larger review by the California Technology Assessment Forum of new hepatitis C drugs.
- "Medical Groups Question Price of New Hep C Drug" (Perrone, AP/Bradenton Herald, 3/11).